tradingkey.logo
tradingkey.logo
Buscar

BioLife Solutions Inc

BLFS
Añadir a la lista de seguimiento
28.110USD
-0.380-1.33%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.37BCap. mercado
PérdidaP/E TTM

Más Datos de BioLife Solutions Inc Compañía

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

Información de BioLife Solutions Inc

Símbolo de cotizaciónBLFS
Nombre de la empresaBioLife Solutions Inc
Fecha de salida a bolsaNov 22, 1989
Director ejecutivoDe Greef (Roderick)
Número de empleados159
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 22
DirecciónSuite 310
CiudadBOTHELL
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal98021
Teléfono14254011400
Sitio Webhttps://www.biolifesolutions.com/
Símbolo de cotizaciónBLFS
Fecha de salida a bolsaNov 22, 1989
Director ejecutivoDe Greef (Roderick)

Ejecutivos de BioLife Solutions Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
292.78K
-0.41%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
132.07K
-1.49%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
66.03K
-154.97%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
47.83K
-0.88%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
44.99K
-2.88%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
-143.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
292.78K
-0.41%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
132.07K
-1.49%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
66.03K
-154.97%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
47.83K
-0.88%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
44.99K
-2.88%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de BioLife Solutions Inc?

Los cinco principales accionistas de BioLife Solutions Inc son: Dr. Aby J. Mathew, Ph.D.

¿Cuántas instituciones poseen acciones de BioLife Solutions Inc (BLFS)?

A fecha de 2026Q1, 430 instituciones poseen acciones de BioLife Solutions Inc, con un valor de mercado combinado de aproximadamente 51.34M, lo que representa el 105.07% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1261408.00.